9-Methyl-beta-carboline (9-Me-BC) is a synthetic heterocyclic amine of the β-carboline family. Methylation at the N-9 position produces a unique profile of dopaminergic neurostimulation, neuroprotection, and neuroregenerative activity.
Dopamine Synthesis Stimulation
The primary mechanism is upregulation of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine biosynthesis. In primary mesencephalic cultures, 9-Me-BC doubles the number of TH⁺ neurons. The effect is independent of D2/D3 receptors (sulpiride blockade does not abolish the response) and is mediated via the PI3K cascade. A 2012 study (J. Neurochem.) in rats demonstrated significant hippocampal dopamine elevation alongside dendritic and synaptic proliferation, accompanied by improved cognitive performance in behavioral tests.
MAO Inhibition
Reversible inhibitor of MAO-A (IC₅₀ = 1 μM) and MAO-B (IC₅₀ = 15.5 μM). Reduced dopamine degradation in the synaptic cleft synergizes with TH upregulation: the compound simultaneously increases synthesis and extends neurotransmitter dwell time.
Neurogenesis and Neurite Outgrowth
Stimulates differentiation of progenitors into mature dopaminergic neurons, increases dendritic arborization and synaptic density. Via astrocytes, upregulates BDNF, GDNF (Artn), TGF-β2, and NCAM1. Restores dopaminergic neurons after chronic rotenone treatment in vitro; reduces α-synuclein levels in parkinsonism models.
Anti-inflammatory Activity
Suppresses microglial proliferation and reduces chemotactic cytokine levels in the CNS.
Photosensitization
The compound may induce UV photosensitivity. Store in dark opaque containers, protect from direct light exposure.
BIOLABCHEMICALS